Purchase Order HHSN272201701116P

The Bureau of Medicine and Surgery awarded a $23,152.98 firm fixed-price purchase order to Biosearch Technologies, Inc. for a DLO-FBP-2 5' FAM BHQPlus Probe on June 28, 2021, with completion targeted for July 30, 2021. This contract, which utilized no set-aside designation, was executed through open competition. Biosearch Technologies, a specialized manufacturer of oligonucleotide-based molecular biology tools headquartered in Petaluma, California and operating through its LGC Biosearch...

The Food and Drug Administration (FDA) awarded a $94,500 firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned manufacturer of protein biomarker analysis technologies and services. The contract is for quantitative proteomics measurement of cardiotoxicity biomarkers in 150 human plasma samples using Olink's proprietary Explore 1536 multiplex analysis platform. This purchase order was awarded without a set-aside and is not associated with a larger contract vehicle. Olink...

<p>This is a firm fixed-price purchase order awarded by the Southeast Area division of a civilian federal agency to Bioproximity LLC, a for-profit limited liability company, for $22,200.00. The contract is for quantitative proteomic profiling of Arabidopsis samples, and has an ultimate completion date of September 28, 2018. The contract does not have a set-aside designation. No additional context about the agency's programs is provided.</p>

Proimmune, Inc. was awarded a definitive contract by the Department of Health and Human Services' Food and Drug Administration (FDA) to conduct a comparison of CRISPR-associated protein 9 (Cas9) derived from different organisms. Specifically, the contract calls for Proimmune to perform a dendritic cell-T cell proliferation assay and an antigen presenting assay, also known as major histocompatibility complex class II-associated peptide proteomics assay, to analyze Cas9 proteins. The potential...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Activx Biosciences, Inc., a foreign-owned for-profit organization. The $180,600 contract is for kinase profiling services, with a completion date of November 29, 2022. Activx Biosciences has previously provided similar drug discovery and profiling services to other NIH entities such as the National Cancer Institute...

Promega Corporation received a contract award from the National Center for Advancing Translational Sciences (NCATS) for $14,535.00 to supply CellTiter-Glo Solution, a luminescent cell viability assay reagent commonly used in high-throughput screening and drug development applications. The award, issued on December 8, 2014, with an ultimate completion date of February 28, 2015, was executed as a call against Promega's existing Blanket Purchase Agreement (BPA) with the National Institutes of...

This contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Applikon Biotechnology, Inc. for the provision of an Acoustic Wave Perfusion System. The contract is a firm fixed price Purchase Order with a potential value of $111,704.00 and a completion date of May 31, 2021. No set-aside designation was used for this award. Applikon Biotechnology, Inc. is a for-profit organization that supplies bioreactors, fermenters, and related equipment to...

The Department of Health and Human Services Food and Drug Administration (FDA) awarded a Firm Fixed Price purchase order to Bhayana Brothers LLC, a minority-owned, for-profit limited liability company, for the provision of a Bioprofile Flex2 System bioanalyzer. This $124,260.00 contract was not set aside. The bioanalyzer is required to monitor metabolites in cell culture media, including pH, dissolved gases, and key nutrients, to support the FDA's stem cell research and bioreactor operations....

Promega Corporation was awarded a firm fixed-price BPA call valued at $24,519.90 by the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health. The contract, awarded on September 25, 2015, with an ultimate completion date of February 29, 2016, procures CellTiter-Fluor cell viability assay reagents (2 x 50mL) and other associated reagents for use by NCATS staff member Menghang Xia. The work will be performed at Promega's Madison, Wisconsin...

This is a $79,345.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract is for quantitative proteomics measurement of human COVID-19 plasma samples, which supports the FDA's research efforts related to the COVID-19 pandemic. Olink Proteomics specializes in protein biomarker discovery and has provided a range of proteomics instruments, reagents, and analysis services to various...